Search Within

Lisa M Butler-van Den Heuvel

Formats
  1. Journal Article (6)
  2. Meeting Abstract (2)
Groups
  1. Department of Medicine (5)
  2. Genitourinary Oncology Service (5)
  3. Solid Tumor Oncology Division (5)
  4. Center for Hematologic Malignancies (4)
  5. Pediatric Leukemia (4)
  6. Pediatrics, Department of (4)

More Groups

People
  1. Paul Marks (8)
  2. Richard Rifkind (8)
  3. Victoria Richon (8)
  4. Howard Scher (5)
  5. Michael La Quaglia (4)
  6. Brian Higgins (3)

More People

Years
  1. 2003 (1)
  2. 2002 (2)
  3. 2001 (2)
  4. 2000 (3)
Publications
  1. Cancer Research (2)
  2. Clinical Cancer Research (2)
  3. Proceedings of the American Association for Cancer Research Annual Meeting (2)
  4. Medical and Pediatric Oncology (1)
  5. Proceedings of the National Academy of Sciences of the United States of America (1)
Publishers
  1. American Association for Cancer Research (6)
  2. National Academy of Sciences (1)
  3. Wiley Liss (1)

Results (8)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Histone deacetylase inhibitors induce growth suppression and cell death in human rhabdomyosarcoma in vitro
    Journal Article

    Kutko, M. C.; Glick, R. D.; Butler, L. M.; Coffey, D. C.; Rifkind, R. A.; Marks, P. A.; Richon, V. M.; LaQuaglia, M. P.
    Clinical Cancer Research (2003)

    Fulltext@MSK | Save
  • The histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) induces thioredoxin-binding protein-2 which blocks thioredoxin function
    Meeting Abstract

    Butler, L. M.; Zhou, X.; Scher, H. I.; Rifkind, R. A.; Marks, P. A.; Richon, V. M.
    Proceedings of the American Association for Cancer Research Annual Meeting (2002)

    Fulltext@MSK | Save
  • The histone deacetylase inhibitor SAHA arrests cancer cell growth, up-regulates thioredoxin-binding protein-2, and down-regulates thioredoxin
    Journal Article

    Butler, L. M.; Zhou, X.; Xu, W. S.; Scher, H. I.; Rifkind, R. A.; Marks, P. A.; Richon, V. M.
    Proceedings of the National Academy of Sciences of the United States of America (2002)

    Fulltext@MSK | Save
  • Inhibition of transformed cell growth and induction of cellular differentiation by pyroxamide, an inhibitor of histone deacetylase
    Journal Article

    Butler, L. M.; Webb, Y.; Agus, D. B.; Higgins, B.; Tolentino, T. R.; Kutko, M. C.; LaQuaglia, M. P.; Drobnjak, M.; Cordon-Cardo, C.; Scher, H. I.; more...
    Clinical Cancer Research (2001)

    Fulltext@MSK | Save
  • The histone deacetylase inhibitor, CBHA, inhibits growth of human neuroblastoma xenografts in vivo, alone and synergistically with all-trans retinoic acid
    Journal Article

    Coffey, D. C.; Kutko, M. C.; Glick, R. D.; Butler, L. M.; Heller, G.; Rifkind, R. A.; Marks, P. A.; Richon, V. M.; La Quaglia, M. P.
    Cancer Research (2001)

    Fulltext@MSK | Save
  • Hybrid polar inhibitors of histone deacetylase suppress the growth of the CWR22 human prostate cancer xenograft
    Meeting Abstract

    Butler, L. M.; Higgins, B.; Fox, W. D.; Agus, D. B.; Cordon-Cardo, C.; Scher, H. I.; Richon, V. M.; Rifkind, R. A.; Marks, P. A.
    Proceedings of the American Association for Cancer Research Annual Meeting (2000)

    Fulltext@MSK | Save
  • Histone deacetylase inhibitors and retinoic acids inhibit growth of human neuroblastoma in vitro
    Journal Article

    Coffey, D. C.; Kutko, M. C.; Glick, R. D.; Swendeman, S. L.; Butler, L.; Rifkind, R.; Marks, P. A.; Richon, V. M.; LaQuaglia, M. P.
    Medical and Pediatric Oncology (2000)

    Fulltext@MSK | Save
  • Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses the growth of prostate cancer cells in vitro and in vivo
    Journal Article

    Butler, L. M.; Agus, D. B.; Scher, H. I.; Higgins, B.; Rose, A.; Cordon-Cardo, C.; Thaler, H. T.; Rifkind, R. A.; Marks, P. A.; Richon, V. M.
    Cancer Research (2000)

    Fulltext@MSK | Save